https://charts.traderzeitung.de/phases/US04272N1028
string(1402) "{"isin":"US04272N1028","name":"ArriVent BioPharma Inc","stock_id_xnas":38983972,"stock_id_xnys":null,"generated_at":"2026-08-21 09:55:00","days":[{"date":"2026-08-18","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":30.03,"close_at":"2026-08-18 21:59:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-08-19","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":30.01,"close_at":"2026-08-19 21:59:00","complete":true,"perf_pct":-0.0666},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-08-20","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":29.188,"close_at":"2026-08-20 21:59:00","complete":true,"perf_pct":-2.7391},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]}]}"
ArriVent BioPharma Aktie News & Nachrichten

ArriVent BioPharma Aktie News & Nachrichten

[WKN: A4016H | Symbol: AVBP]
Realtimekurs
   
Vorbörsliche Indikationen
Regulärer Handel
Nachbörslicher Handel

ArriVent Biopharma: Truist Securities empfiehlt den Kauf mit einem Kursziel von 43 USD!

ArriVent Biopharma (AVBP) positioniert sich als ein klinisches Pharmaunternehmen, das sich der globalen...

TOP-5-Kursziele der Analysten am 25.11.25

Firefly Aerospace [US31816X1063] Roth Capital bestätigt Buy-Rating mit Kursziel 30 USD (76 % Kurspotenzial)...

  • 1